Generic drugmaker Endo posts quarterly loss due to charge

Aug 8 (Reuters) – Generic drugmaker Endo International Plcreported a quarterly loss versus a profit a yearearlier, hurt mainly by impairment charges of $725 million.
The post Generic drugmaker Endo posts quarterly loss due to charge appeared first on RocketNews | Top News Stories From Around the Globe.